Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:interferon_beta-1b
gptkb:Ferring gptkb:Ernesto_Bertarelli |
| gptkbp:acquired |
Merck K Ga A
|
| gptkbp:dissolved |
gptkb:2006
|
| gptkbp:employees |
approximately 4,000
|
| gptkbp:founded |
1906
1924 |
| gptkbp:founder |
gptkb:Francois_Serono
|
| gptkbp:headquarters |
gptkb:Geneva,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Serono
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:products |
gptkb:Ovidrel
gptkb:Rebif gptkb:Gonal-f gptkb:Serostim |
| gptkbp:revenue |
$1.5 billion (2005)
|
| gptkbp:services |
Clinical trials
Regulatory affairs Biopharmaceutical development Commercialization support |
| gptkbp:website |
www.serono.com
|